Outcomes of patients with detectable CMV DNA at randomization in the phase III trial of letermovir for the prevention of CMV infection in allogeneic hematopoietic cell transplantation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Outcomes of patients with detectable CMV DNA at randomization in the phase III trial of letermovir for the prevention of CMV infection in allogeneic hematopoietic cell transplantation

Published:2020-01-18 Issue:6 Volume:20 Page:1703-1711
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:Am J Transplant

Author:

Marty Francisco M.¹^ORCID,Ljungman Per T.²,Chemaly Roy F.³,Wan Hong⁴,Teal Valerie L.⁴,Butterton Joan R.⁴,Yeh Wendy W.⁴,Leavitt Randi Y.⁴,Badshah Cyrus S.⁴

Affiliation:

1. Dana‐Farber Cancer Institute and Brigham and Women's Hospital Boston Massachusetts

2. Karolinska University Hospital and Karolinska Institutet Stockholm Sweden

3. MD Anderson Cancer Center University of Texas Houston Texas

4. Merck & Co., Inc. Kenilworth New Jersey

Funder

Merck Sharp and Dohme

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajt.15764

Reference13 articles.

1. Cytomegalovirus in hematopoietic stem cell transplant recipients: current status, known challenges, and future strategies

2. Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients

3. Definitions of Cytomegalovirus Infection and Disease in Transplant Recipients

4. Complications, Diagnosis, Management, and Prevention of CMV Infections: Current and Future

5. CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMT

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Abordagem à Infeção pelo Vírus Citomegálico em Doentes Submetidos a Transplante Alogénico de Progenitores Hematopoiéticos;Acta Médica Portuguesa;2024-07-15

2. Clinical Pharmacokinetics and Pharmacodynamics of Letermovir in Allogenic Hematopoietic Cell Transplantation;Clinical Pharmacokinetics;2024-07

3. Real-World Safety and Effectiveness of Letermovir in Patients Undergoing Allogenic Hematopoietic Stem Cell Transplantation: Final Results of Post-Marketing Surveillance in Japan;Clinical Drug Investigation;2024-06-27

4. Letermovir as cytomegalovirus prophylaxis in children undergoing allogeneic hematopoietic cell transplantation;Bone Marrow Transplantation;2024-05-21

5. Advances in pharmacotherapies for cytomegalovirus infection: what is the current state of play?;Expert Opinion on Pharmacotherapy;2024-04-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3